Publication:
Endogenous retroviruses shape pluripotency specification in mouse embryos.

dc.contributor.authorde la Rosa, Sergio
dc.contributor.authorDel Mar Rigual, María
dc.contributor.authorVargiu, Pierfrancesco
dc.contributor.authorOrtega Jimenez, Sagrario
dc.contributor.authorDjouder, Nabil
dc.contributor.funderMinisterio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España)
dc.contributor.funderComunidad de Madrid (España)
dc.contributor.funderAsociación Española Contra el Cáncer
dc.contributor.funderMinisterio de Ciencia e Innovación (España)
dc.date.accessioned2024-02-08T21:47:23Z
dc.date.available2024-02-08T21:47:23Z
dc.date.issued2024-01-26
dc.description.abstractThe smooth and precise transition from totipotency to pluripotency is a key process in embryonic development, generating pluripotent stem cells capable of forming all cell types. While endogenous retroviruses (ERVs) are essential for early development, their precise roles in this transition remains mysterious. Using cutting-edge genetic and biochemical techniques in mice, we identify MERVL-gag, a retroviral protein, as a crucial modulator of pluripotent factors OCT4 and SOX2 during lineage specification. MERVL-gag tightly operates with URI, a prefoldin protein that concurs with pluripotency bias in mouse blastomeres, and which is indeed required for totipotency-to-pluripotency transition. Accordingly, URI loss promotes a stable totipotent-like state and embryo arrest at 2C stage. Mechanistically, URI binds and shields OCT4 and SOX2 from proteasome degradation, while MERVL-gag displaces URI from pluripotent factor interaction, causing their degradation. Our findings reveal the symbiotic coevolution of ERVs with their host cells to ensure the smooth and timely progression of early embryo development.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipacknowledgments: We thank all mouse providers as described in Materials and Methods. We also thank the cniO Animal Facility for mouse maintenance. We acknowledge M. Ko (Keio University, Systems Medicine, Japan) for providing the pZscan4- emerald reporter plasmid. Funding: S.d.l.R. was supported by a fellowship from the comunidad de Madrid and by funds from the Severo Ochoa- cniO. this work was funded by grants to n.d. supported by the State Research Agency (Aei; 10.13039/501100011033) from the Spanish Ministry of Science and innovation (Rti2018- 094834- B- i00 and Pid2021- 122695OB- i00), also including the idiFFeR network of excellence (Red2022- 134792- t), cofunded by european Regional development Fund (eRdF), by the comunidad Autónoma de Madrid (S2017/BMd- 3817), and by the Asociación española contra el cáncer (Aecc) (PRYGn211184dJOU). this work was developed at the cniO funded by the health institute carlos iii (iSciii) and the Spanish Ministry of Science and innovation. Author contributions: S.d.l.R. designed and performed the experiments and analyzed all the data. S.d.l.R. analyzed all the bioinformatics data. M.d.M.R. performed some experiments. P.v. and S.O. performed microinjection in vivo and chimera embryo assay. S.d.l.R and n.d. developed the project and wrote the manuscript. n.d. conceived the project and secured funding. Competing interests:the authors declare that they have no competing interests. Data and materials availability: All data are available in the main text or Materials and Methods. Materials are available upon request to n.d. and the sharing of materials described in this work will be subject to standard material transfer agreementses_ES
dc.format.number4es_ES
dc.format.pageeadk9394es_ES
dc.format.volume10es_ES
dc.identifier.citationSci Adv . 2024 ;10(4):eadk9394.es_ES
dc.identifier.doi10.1126/sciadv.adk9394es_ES
dc.identifier.e-issn2375-2548es_ES
dc.identifier.journalScience advanceses_ES
dc.identifier.pubmedID38266080es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/17673
dc.language.isoenges_ES
dc.publisherAmerican Association for the Advancement of Science (AAAS)
dc.relation.publisherversionhttps://doi.org/10.1126/sciadv.adk9394.es_ES
dc.repisalud.institucionCNIOes_ES
dc.repisalud.orgCNIOCNIO::Grupos de investigación::Grupo de Factores de Crecimiento, Nutrientes y Cánceres_ES
dc.repisalud.orgCNIOCNIO::Unidades técnicas::Unidad de Ratones Transgénicoses_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshEndogenous Retroviruseses_ES
dc.subject.meshPluripotent Stem Cellses_ES
dc.subject.meshFemalees_ES
dc.subject.meshPregnancyes_ES
dc.subject.meshAnimalses_ES
dc.subject.meshMicees_ES
dc.subject.meshEmbryo, Mammalianes_ES
dc.subject.meshEmbryonic Developmentes_ES
dc.titleEndogenous retroviruses shape pluripotency specification in mouse embryos.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationaf015f0d-c68f-4f20-aec8-6b591b9a236e
relation.isAuthorOfPublicatione029ea8d-a728-41e5-8035-40ace0841d69
relation.isAuthorOfPublication.latestForDiscoveryaf015f0d-c68f-4f20-aec8-6b591b9a236e
relation.isFunderOfPublication9bec53f6-b1d2-4340-9f6b-91815956d602
relation.isFunderOfPublicationc87c70a3-e023-4b6b-ac25-1b2d1b483786
relation.isFunderOfPublication453a1189-9bca-4be8-8d60-695f50fe028b
relation.isFunderOfPublication289dce42-6a28-4892-b0a8-c70c46cbb185
relation.isFunderOfPublication.latestForDiscovery9bec53f6-b1d2-4340-9f6b-91815956d602
relation.isPublisherOfPublication8b2bb97b-cfcc-4e43-9af6-a0cf9e9fed61
relation.isPublisherOfPublication.latestForDiscovery8b2bb97b-cfcc-4e43-9af6-a0cf9e9fed61

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
endigenousretroviruses_2024.pdf
Size:
22.82 MB
Format:
Adobe Portable Document Format
Description:
Artículo principal